+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Fiducial Markers Market Size, Share and Growth Outlook, 2026: Analysis By Product Composition (Gold Markers, Polymer Markers, Carbon Markers, Platinum Markers, Liquid Markers, Others), By Application (Radiation Therapy Guidance, CT and CBCT Scans, MRI and MEG Scans, PET Scans, Endoscopic Ultrasound Scans), By Placement Location (Head and Neck, Prostate, Lung, Breast, Liver, Pancreas), By End User (Hospitals, Radiotherapy Centers, Cancer Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Fiducial Markers Market size is forecast to increase from $169.59 Million in 2026 to $241.17 Million in 2034 at a CAGR of 4.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007217
Pages: 212 Pages

Fibrotic Disease Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Type (Medication, Organ Transplantation, Oxygen Therapy, Others), By Application (Idiopathic Pulmonary Fibrosis, Hepatic Cirrhosis, Renal Fibrosis, Cutaneous Fibrosis, Others), By End User (Hospitals, Academic & Research Institutes, Specialty Clinics) Companies, and Country Forecast, 2021 to 2034

Global Fibrotic Disease Treatment Market size is forecast to increase from $4.51 Billion in 2026 to $7.98 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007216
Pages: 219 Pages

Fibromyalgia Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Others), By Treatment Type (Symptomatic Treatment, Targeted Treatment), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Companies, and Country Forecast, 2021 to 2034

Global Fibromyalgia Drugs Market size is forecast to increase from $299.13 Million in 2026 to $604.84 Million in 2034 at a CAGR of 9.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007215
Pages: 221 Pages

Fibrinogen Concentrate Market Size, Share and Growth Outlook, 2026: Analysis By Source (Human Plasma-Derived Concentrates, Recombinant), By Application (Congenital Fibrinogen Deficiency, Trauma & Surgery-Related Hemorrhage, Obstetric & Gynecological Bleeding, Others), By Form (Lyophilized Powder Vials, Ready-to-Use Liquid Formulations), By End User (Hospitals, Specialty Clinics & Hemophilia Centers, Military & Emergency Medical Services) Companies, and Country Forecast, 2021 to 2034

Global Fibrinogen Concentrate Market size is forecast to increase from $4.04 Billion in 2026 to $6.64 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007214
Pages: 228 Pages

Fibrin Sealants Market Size, Share and Growth Outlook, 2026: Analysis By Product Delivery Format (Liquid Fibrin Sealants, Spray-Based Fibrin Sealants, Matrix & Gel Formulations, Sheet & Patch-Based Fibrin Sealants), By Biological Source Material (Human Plasma-Derived Sealants, Animal Plasma-Derived , Recombinant Fibrin Sealants ), By Surgical Application (Cardiovascular & Thoracic Surgery, Orthopedic & Spinal Surgery, General Surgery & Tissue Resection, Transplant Surgery, Neurosurgery & Dural Sealing, Trauma & Emergency Care Procedures), By End-User Facility (Hospitals & Central Operating Theaters, Specialty Cardiac, Orthopedic, & Trauma Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Fibrin Sealants Market size is forecast to increase from $1.29 Billion in 2026 to $2.27 Billion in 2034 at a CAGR of 7.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007213
Pages: 214 Pages

Fibrate Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Fenofibrate & Fenofibric Acid, Gemfibrozil, Bezafibrate, Ciprofibrate, Clofibrate, Pemafibrate), By Product Category (Branded Fibrates, Generic Fibrates), By Route of Administration (Oral Formulation , Parenteral ), By Clinical Indication (Hypertriglyceridemia, Mixed Dyslipidemia, Cardiovascular Disease Prevention & Adjuvant Statin Therapy, Diabetic Retinopathy Prevention), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Community Drugstores, Online) Companies, and Country Forecast, 2021 to 2034

Global Fibrate Drugs Market size is forecast to increase from $3.89 Billion in 2026 to $6.07 Billion in 2034 at a CAGR of 5.72% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007212
Pages: 220 Pages

Fetal Monitoring Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Ultrasound Imaging Devices , Electronic Fetal Monitors , Uterine Contraction Monitors, Fetal Electrodes & Internal Sensors, Telemetry & Wireless Connectivity Devices, Fetal Doppler Hardware, Accessories and Consumables), By Portality (Non-Portable , Portable & Handheld Systems), By Clinical Method (Non-Invasive Monitoring, Invasive Monitoring), By Gestational Application Phase (Antepartum Care Monitoring , Intrapartum Care Monitoring ), By End-User Facility (Hospitals & Labor Delivery Rooms, Obstetrics & Gynecology Specialty Clinics, Home Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Fetal Monitoring Market size is forecast to increase from $0.75 Billion in 2026 to $1.32 Billion in 2034 at a CAGR of 7.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007211
Pages: 227 Pages

Fetal Monitoring Bands Market Size, Share and Growth Outlook, 2026: Analysis By Band Construction & Material Usability (Reusable Elastic , Single-Use , Latex-Free & Hypoallergenic Monitoring Bands), By Technology Compatibility (Tocodynamometer , Ultrasound Transducer , Electrohysterography ), By Connectivity Profile (Traditional Wired Band Frameworks, Smart ), By Application Phase (Antepartum , Intrapartum , High-Risk Pregnancy Management), By End-User (Hospitals & Labor Delivery Rooms, Specialty Obstetric & Maternity Clinics, Home Care Settings & Remote Telehealth Monitoring Platforms) Companies, and Country Forecast, 2021 to 2034

Global Fetal Monitoring Bands Market size is forecast to increase from $220.88 Billion in 2026 to $365.56 Billion in 2034 at a CAGR of 6.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007210
Pages: 229 Pages

Fetal Doppler Market Size, Share and Growth Outlook, 2026: Analysis By Device Design & System Configuration (Pocket , Desktop & Table-top Fetal Dopplers, Wireless ), By Display Technology (Digital LCD, Audio-Only Fetal Dopplers), By Clinical Indication (Early-Gestation Monitoring , Late-Gestation & High-Risk Pregnancy Monitoring), By End-User Setting (Hospitals & Inpatient Obstetric Units, Gynecology & Prenatal Specialty Clinics, Home Care Settings & Expectant Parents, Community Healthcare & Midwife Services) Companies, and Country Forecast, 2021 to 2034

Global Fetal Doppler Market size is forecast to increase from $291.4 Million in 2026 to $467.96 Million in 2034 at a CAGR of 6.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007209
Pages: 228 Pages

Fetal Bovine Serum Market Size, Share and Growth Outlook, 2026: Analysis By Product (Standard , Heat-Inactivated FBS, Charcoal , Dialyzed FBS, Stem-Cell-Qualified FBS, Exosome-Depleted FBS, Chromatographically Purified & Specialty FBS), By Physical Form (Liquid Form FBS, Powdered ), By Application Category (Cell-Based Research & Cell Culture Maintenance, Biopharmaceutical Manufacturing , Vaccine Production , Drug Discovery & Preclinical Studies, In-Vitro Fertilization , Molecular Diagnostics & IVD Development), By End-User (Biotechnology & Pharmaceutical Companies, Academic, University, & Government Research Institutes, Contract Development & Manufacturing Organizations , Cell Banks & Biorepositories, Diagnostic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Fetal Bovine Serum Market size is forecast to increase from $3.06 Billion in 2026 to $8.49 Billion in 2034 at a CAGR of 13.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007208
Pages: 230 Pages